Save the Date for Applied Pharmaceutical Analysis 2019!
September 9-11, 2019
Revere Hotel Boston Common
200 Stuart Street
Boston, MA 02116
APA 2019 Plenary Speakers
![]() |
Paula Annunziato, MD, Vice President and Therapeutic Head, Vaccines Clinical Research, MerckVaccine Development - Title TBA
|
|
![]() |
Samir M. Hanash, MD, PhD, Professor, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer CenterTitle TBA |
|
![]() |
Nina Isoherranen, PhD, Professor, Vice Chair, Pharmaceutics, Department of Pharmaceutics, University of WashingtonTitle TBA |
|
![]() |
Irina Koroleva, PhD, Director, Translational Medicine, Rubius TherapeuticsTitle TBA |
APA 2019 Confirmed Speakers
Arjun Arumugam, M.D., Executive Director, Azidus Laboratories Limited
Mark Dysinger, Development Scientist, Bioanalytical Development, Alexion Pharmaceuticals
Mireia Fernandez Ocana, Ph.D., Global Biomarker Discovery Lead, Drug Safety (Assoc. Dir.), Pfizer
Jaya Goyal, Ph.D., Vice President, Bioanalytical, Pharmacology and Biomarker Development, Wave Life Sciences Ltd.
Huidong Gu, Senior Research Scientist II, Bristol-Myers Squibb
Hyunyoung (Young) Jeong, Ph.D., Professor, University of Illinois at Chicago
Amit Kalgutkar, Ph.D., Research Fellow, Pfizer
Colleen Kelly, M.D., Assistant Professor of Medicine, The Warren Alpert Medical School, Brown University
Jean-Claude Marshall, Ph.D., Head of Clinical Biomarker Technologies, Pfizer
Mark Milton, Ph.D., Ophthalmology Therapeutic Area Head, PK Sciences, Novartis Institutes for BioMedical Research (NIBR)
Kaushik Mitra, Ph.D., Director, Molecular and Investigative Toxicology, Merck
Leila Pirhaji, Ph.D., Founder and CEO, ReviveMed
Brooke Rock, Ph.D., Principal Scientist at Amgen
Yu Tian, Ph.D., Director, AbbVie
Esther van Duijn, Ph.D., Scientist, TNO (Netherlands Organisation for Applied Scientific Research)
Sheri Wilcox, Senior Director, SomaLogic
Fan Wu, Senior Principal Scientist, Celgene Corporation
APA 2019 Invited Speakers
John Kadavil, Ph.D.,Deputy Director, CDER/OTS/OSIS/DGDBE, U.S. Food and Drug Administration
Michael Skelly, Ph.D., Lead Pharmacologist, CDER/OTS/OSIS, U.S. Food and Drug Administration
Proposed Sessions for APA 2019 Workshops
Regulated Bioanalysis
FDA/Regulatory Session
Digital State of Regulated Bioanalysis – Cloud Storage & Data Security
2018 FDA BMV Guidance/ICH M10
Bioanalytical Support of Novel Therapies and New Modalities in Clinical Development
Frontiers of Biomarker Bioanalysis
Discovery Bioanalysis and New Technologies
Novel modalities, guidance for new modalities
Cellular and Gene Therapies
Omics
Advanced LC-MS and Applications of HRMS
AI Session - Predict the Structure
Mechanistic ADME
From Accidents to Innovation: Serendipity in Drug Discovery
Not Your Average Human ADME Study
DILI/RM/Weird Metabolite - How NMR Saved the Day
Improved Clinical Outcomes Through Modeling
Insights and Development Challenges of New Modalities
Expanding Horizons - Beyond Mechanistic ADME and Bioanalysis Workshop (NASH/Fibrosis/Microbiome)
APA 2018 Conference Program